PharmaShots | Incisive News in 3 Shots

Subscribe Now

Israel

Kamada to Commercialize Three Biosimilar Products in Israel

Kamada to Commercialize Three Biosimilar Products in Israel

January 14, 2021

Prestige Signs an Exclusive Agreement with Teva to Commercialize Tuznue (biosimilar- trastuzumab) in Israel

Prestige Signs an Exclusive Agreement with Teva to Commercialize Tuznue (biosimilar- trastuzumab) in Israel

November 11, 2020

Kamada Collaborates with Alvotech to Commercialize its Six Biosimilar Products in Israel

Kamada Collaborates with Alvotech to Commercialize its Six Biosimilar Products in Israel

December 3, 2019

AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel

AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel

November 29, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us